NuVasive Q3 Income at $7M, Up Nearly 250% From Last Year

NuVasive reported its consolidated net income in the third quarter of $7.3 million, up nearly 250 percent compared to the same period last year.

Advertisement

The company reported $169 million in total third quarter revenue, up 14 percent from the same period last year. Spine revenue also jumped this past quarter, up 16 percent to $131 million. Biologics and monitoring services experienced modest increases.

More Articles on Devices:
Device Companies — 7 Key Notes — Zimmer, Boston Scientific & More
Baxano Surgical Granted Patent for Visual Approach of Lateral Access Fusion System
Orthozon Technologies’ Lumiere Retractor System Recognized as Top Device for Spine

 

Advertisement

Next Up in Spinal Tech

  • Zavation Medical has acquired ChoiceSpine, and Derek Kuyper will be CEO of the combined company, according to a Feb. 26…

  • Carlsmed saw significant gains in fourth-quarter and 2025 revenue, according to financial results posted Feb. 25. Five things to know:…

Advertisement

Comments are closed.